ClinicalTrials.Veeva

Menu

A Setting Focus Overdose Prevention Intervention (Oasis)

Johns Hopkins Bloomberg School of Public Health logo

Johns Hopkins Bloomberg School of Public Health

Status

Enrolling

Conditions

HCV
HIV Infections
Drug Overdose

Treatments

Behavioral: HIV, HCV and overdose prevention

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05320835
R01DA050470
IRB00019139 (Other Identifier)

Details and patient eligibility

About

A pilot injection-setting targeted peer-driven intervention to reduce HIV and hepatitis C virus transmission and overdose risk behaviors among people who inject drugs (PWID).

Full description

This is a pilot of an injection setting targeted peer-driven intervention to reduce HIV/HCV transmission and overdose risk behaviors. Participants will be randomized to conditions: 1) Peer education and stocking of semi-public injection settings (SPIS) with risk reduction materials, and the standard of care. Based on their SPIS use, 120 index PWID participants will be selected.

A conceptual model for the intervention: The conceptual model is based on social influence, social network, and social cognitive theory. The prior work delineated social influence mechanisms. It is expected that training and modeling of effective communication skills will increase the occurrence of conversations on HIV/HCV and overdose prevention. These conversations will then alter perceived descriptive and prescriptive social norms of risk behaviors. The prior work is being enhanced by increasing the availability of risk reduction materials as well as the cuing and modeling risk reduction behaviors in risk settings. It has been found that PWID are motivated to conduct peer education; it enhances their status and provides them a prosocial role in the community. It is hypothesized that peer outreach and supply of materials to SPIS will lead to reduced sharing of injection equipment and increased naloxone availability.

Enrollment

285 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Current drug user (opioid use in the prior two weeks)

Exclusion criteria

  • Any mental or physical health impairment that impedes ability to participate

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

285 participants in 2 patient groups

Experimental
Experimental group
Description:
behavioral training with 6 sessions
Treatment:
Behavioral: HIV, HCV and overdose prevention
comparison
Active Comparator group
Description:
Attention control
Treatment:
Behavioral: HIV, HCV and overdose prevention

Trial contacts and locations

1

Loading...

Central trial contact

Lauren Dayton, PhD; Carl Latkin, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems